Over the past several decades, epidemiologic studies have documented declines in sperm count and quality. During the same ...

The popular weight-loss medication Wegovy will soon be available to telehealth companies. ABC News' Dr. Darien Sutton breaks ...

Hims & Hers ( HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk ( NVO) announced a partnership with it and other telehealth platforms to offer patients access to the ...

More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health ...

It pains me to think I won’t be able to fully see my grandchildren’s faces and fully experience the biggest moments of my ...

A batch of the drug is under a limited voluntary recall after a shipping error exposed certain doses to improper temperatures.

Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

Hims & Hers partners with Novo Nordisk to offer Wegovy access online with clinical support, expanding its weight loss care and revenue strategy.

Hims & Hers on Tuesday announced a collaboration with drugmaker Novo Nordisk to bundle Wegovy and a Hims & Hers membership on its telehealth platform.

Novo Nordisk, the maker of Wegovy, announced exclusively on " Good Morning America " Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...

Novo Nordisk collaborates with telehealth companies to expand sales and access to its weight-loss drug Wegovy, amidst efforts ...